4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-23-059998
Chief Financial Officer sold 294 shares at $11.51 ($3,384)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas Chief Financial Officer | 2023-12-27 | Sale | −294 | $11.51 | $3,384 | 143,851 | D |
| Open-market sales · 294 sh · avg $11.51 · $3,384 | |||||||
Loading xslF345X05/doc4.xml…